Healthcare & Pharma

“For decades, innovation in wellness has meant discovering more and more compounds, higher dosages, newer molecules. With VignanaVeda, we are choosing to understand better. This is where we decode the intelligence of Ayurvedic botanicals…
Read More...

“We have always believed that strong local capabilities are key to resilient healthcare ecosystems. By combining Zydus’ global experience and manufacturing excellence with Sunshine Holdings’ local expertise, this collaboration marks an…
Read More...

“The pharmaceutical industry is increasingly looking at packaging as a strategic tool whether it is strengthening traceability, supporting patient safety or enabling greater visibility across the supply chain. InnoPack Pharma Confex is a…
Read More...

“Sustainability is becoming one of the defining measures of excellence in our industry. The ability to innovate, grow and create impact must be matched by an equal commitment to operating responsibly. Securing the EcoVadis Platinum Rating…
Read More...

“This ₹2,000 crore investment will further strengthen Madhya Pradesh’s position as a key manufacturing and export hub, while contributing to economic development and industrial advancement. The Government of Madhya Pradesh remains committed…
Read More...

“Healthcare organizations are under increasing pressure to operate more efficiently while continuing to deliver exceptional patient experiences. I’m excited to build on Coronis Health’s strong foundation and help shape its…
Read More...

“India represents an important growth market for Align, and we are excited about the opportunity to expand our global manufacturing network with a new facility in Hyderabad.” Jitse Marrée, Align Executive Vice President, Global Operations.…
Read More...

“Quantum Ayurveda is not a product innovation — it is a processing revolution. For centuries, India has given the world its most powerful botanicals. What we are now adding is the science of how those botanicals can be made to perform at…
Read More...

“India’s transition from a generics-led to an innovation-led pharmaceutical economy will not be made by any single institution or any single company. It will be made by the academia-industry network we are building across the country. Two…
Read More...

“We are delighted to welcome Shyamakant to the Apothecon Group. His extensive leadership experience across global pharmaceutical and healthcare businesses makes him well-suited to lead the Company through its next phase of growth. We are…
Read More...